Neural Wiskott-Aldrich syndrome protein (WASL) (C-Term) Antikörper
-
- Target Alle Neural Wiskott-Aldrich syndrome protein (WASL) Antikörper anzeigen
- Neural Wiskott-Aldrich syndrome protein (WASL)
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- Affinity purification
- Immunogen
- C-terminal region of human WASL
- Top Product
- Discover our top product WASL Primärantikörper
-
anti-Neural Wiskott-Aldrich syndrome protein (WASL) antibody
WASL Reaktivität: Human, Maus, Ratte WB, IF, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Neural Wiskott-Aldrich syndrome protein (WASL) (AA 97-184) antibodyWASL Reaktivität: Human WB, IF, ELISA, IHC (p) Wirt: Maus Monoclonal 5F4 unconjugated
anti-Neural Wiskott-Aldrich syndrome protein (WASL) (Middle Region) antibodyWASL Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Pferd, Schwein, Kaninchen WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Neural Wiskott-Aldrich syndrome protein (WASL) (AA 165-198), (N-Term) antibodyWASL Reaktivität: Maus, Ratte WB Wirt: Kaninchen Polyclonal RB52982 unconjugated
anti-Neural Wiskott-Aldrich syndrome protein (WASL) (AA 1-505) antibodyWASL Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Neural Wiskott-Aldrich syndrome protein (WASL) antibodyWASL Reaktivität: Human, Maus, Ratte WB, IF, IC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- 0.01 % Sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
-
- Target
- Neural Wiskott-Aldrich syndrome protein (WASL)
- Andere Bezeichnung
- WASL (WASL Produkte)
- Molekulargewicht
- 55 kDa
- UniProt
- O00401
-
